As of now, the legal status of cannabis in the United States is a complex and evolving issue. While cannabis remains illegal under federal law, several states have taken steps to legalize its use for medical and recreational purposes.

Currently, 36 states and the District of Columbia have legalized medical cannabis, allowing patients with qualifying conditions to access this treatment option. Additionally, 17 states and D.C. have also legalized recreational cannabis for adult use.

However, despite these state-level changes, cannabis is still classified as a Schedule I controlled substance under federal law. This means that it is considered to have a high potential for abuse and no accepted medical use, making its possession, distribution, and cultivation illegal at the federal level.

The discrepancy between state and federal laws has created challenges for individuals and businesses operating in the cannabis industry. While some states have established regulatory frameworks for the legal production and sale of cannabis, these businesses still face risks such as federal prosecution, banking limitations, and tax issues.

In recent years, there have been efforts at the federal level to address these conflicts. For example, Congress has passed legislation such as the Rohrabacher–Blumenauer amendment which prohibits the Department of Justice from using federal funds to interfere with state medical cannabis laws. Additionally, there are ongoing discussions about potential reforms to federal cannabis laws that could provide clarity and consistency across the country.

Overall, the legal status of cannabis in the United States is a dynamic issue with both progress and challenges. As more states continue to legalize cannabis for medical and recreational use, it remains to be seen how federal laws will evolve to reflect these changes in public opinion and policy.